Guillermo Debén

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Miguel Á. Sanz, Consuelo Rayón, Jordi Esteve et al. · PubMed · 1999 · 410 citations

Medicine, Oncology, Pharmacology +15

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

Pau Montesinos, Juan Bergua, Edo Vellenga et al. · Blood · 2008 · 364 citations · Full text

Medicine, Hematology, Oncology +17

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

Javier de la Serna, Pau Montesinos, Edo Vellenga et al. · Blood · 2008 · 350 citations · Full text

Medicine, Hematology, Oncology +14

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry

Sandra Quijano, Antonio López, Juan‐Manuel Sancho et al. · Journal of Clinical Oncology · 2009 · 215 citations · Full text

Medicine, Hematology, Oncology +17

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

E. Condé, Montserrat Arnán, Miguel Canales et al. · Haematologica · 2008 · 170 citations · Full text

Medicine, Immunology, Oncology +14